Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression

A Novel CXCR3-B Chemokine Receptor-induced Growth-inhibitory Signal in Cancer Cells Is Mediated through the Regulation of Bach-1 Protein and Nrf2 Protein Nuclear Translocation

(2013) Murugabaskar Balan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma

(2012) G. T. Gibney et al.   ANNALS OF ONCOLOGY

Heme Oxygenase-1 in Tumor Biology and Therapy

(2012) Halina Was et al.   CURRENT DRUG TARGETS

The HGF Receptor/Met Tyrosine Kinase Is a Key Regulator of Dendritic Cell Migration in Skin Immunity

(2012) J.-H. Baek et al.   JOURNAL OF IMMUNOLOGY

HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors

(2012) S Gusenbauer et al.   ONCOGENE

Improvement of Sepsis by Hepatocyte Growth Factor, an Anti-Inflammatory Regulator: Emerging Insights and Therapeutic Potential

(2012) Shinya Mizuno et al.   Gastroenterology Research and Practice

NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1 

(2011) T.-H. Kim et al.   CANCER RESEARCH

A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells

(2011) Eshu Singhal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Heme Oxygenase-1 Protein Is Overexpressed in Human Renal Cancer Cells following Activation of the Ras-Raf-ERK Pathway and Mediates Anti-Apoptotic Signal

(2011) Pallavi Banerjee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

HO-1–STAT3 axis in mouse liver ischemia/reperfusion injury: Regulation of TLR4 innate responses through PI3K/PTEN signaling

(2011) Bibo Ke et al.   JOURNAL OF HEPATOLOGY

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth

(2011) F. M. Yakes et al.   MOLECULAR CANCER THERAPEUTICS

Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma

(2010) S. Pilon-Thomas et al.   JOURNAL OF IMMUNOLOGY

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells

(2010) M. Benkhoucha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase-1-dependent mechanism

(2009) Miyuki Kamimoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells

(2009) D. Datta et al.   CANCER RESEARCH

Myeloid heme oxygenase–1 regulates innate immunity and autoimmunity by modulating IFN-β production

(2009) Sotiria Tzima et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Chromosomal abnormalities of clear cell renal cell carcinoma: Frequent gain of chromosome 7

(2009) Naoto Kuroda et al.   PATHOLOGY INTERNATIONAL

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology